Clinical effectiveness and safety of low cost versus innovator brand amlodipine in hypertension: A single-blinded, randomized, crossover, noninferiority trial

OBJECTIVES: A single-blinded, randomized, crossover, noninferiority trial was conducted to evaluate clinical effectiveness and safety of low-cost brand (LCB) versus innovator brand (IB) amlodipine in essential hypertension. MATERIALS AND METHODS: The primary end-point was change of systolic blood pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Alak Kumar, Chatterjee, Suparna, Pal, Jyotirmoy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155474/
https://www.ncbi.nlm.nih.gov/pubmed/28066111
http://dx.doi.org/10.4103/0253-7613.194844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155474/
https://www.ncbi.nlm.nih.gov/pubmed/28066111
http://dx.doi.org/10.4103/0253-7613.194844

Ejemplares similares